David Harle

Dr Harle has over 25 years of pharmaceutical experience in clinical development, strategic regulatory affairs, pharmacovigilance, QA and business development. He commenced his career at 3M Pharmaceuticals Australia in 1990 and went on to manage the medical department of Knoll Australia. In 1997, he established the Australian office of ICON Clinical Research (a global CRO) and the Asia-Pacific regional office located in Singapore in 1999 and held roles with increasing responsibility including VP Clinical Operations for Asia-Pacific, Latin America, Canada and South Africa. He has also held the role of Head, Scientific Affairs at Sandoz Australia. Dr Harle has a BSc (Hons) and PhD (diagnosis and mechanisms of anaphylactic reactions to anaesthetic agents) from the University of Sydney and has authored 26 scientific publications.